Aytu Biopharma (AYTU) Change in Inventory (2015 - 2026)
Aytu Biopharma (AYTU) posted quarterly Change in Inventory of -$543000.0 for Q1 2026, down 990.16% year-over-year from $61000.0 in Q1 2025, and up 10.84% quarter-over-quarter from -$609000.0 in Q4 2025.
Aytu Biopharma (AYTU) Change in Inventory (2015 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Change in Inventory for 12 consecutive years, with -$543000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory fell 990.16% year-over-year to -$543000.0; the TTM figure through Mar 2026 stood at -$1.7 million (down 252.25% YoY), while the FY2025 annual figure was -$382000.0, down 107.92% from the prior year.
- Change in Inventory grew to -$543000.0 in Q1 2026 per AYTU's latest filing, from -$609000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $2.1 million in Q3 2022 and bottomed at -$1.2 million in Q2 2022.
- Historically, Change in Inventory has averaged $233705.9 across 5 years, with a median of $79000.0 in 2022.
- Annual changes were most pronounced in 2022 — Change in Inventory soared 1082.02% — and 2026, when it sank 990.16%.
- Aytu Biopharma's Change in Inventory stood at $79000.0 in 2022, then surged by 765.82% to $684000.0 in 2023, then tumbled by 191.67% to -$627000.0 in 2024, then advanced by 2.87% to -$609000.0 in 2025, then grew by 10.84% to -$543000.0 in 2026.
- Business Quant data shows AYTU's Change in Inventory at -$543000.0 in Q1 2026, -$609000.0 in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn | -543,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -543,000.00 |
| Mar 31, 2026 | -543,000.00 |
| Dec 31, 2025 | -609,000.00 |
| Dec 31, 2025 | -609,000.00 |
| Sep 30, 2025 | -1.06 Mn |
| Sep 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | 518,000.00 |
| Jun 30, 2025 | 518,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | -627,000.00 |
| Dec 31, 2024 | -627,000.00 |
| Sep 30, 2024 | -334,000.00 |
| Sep 30, 2024 | -334,000.00 |
| Jun 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | 1.01 Mn |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 684,000.00 |
| Dec 31, 2023 | 684,000.00 |